The DOI matches its Crossref record.
B-chronic lymphocytic leukemia: a malignancy of anti-self B cells
Abstract
B -CHRONIC lymphocytic leukemia (B-CLL) is the most common leukemia in the western world.It is characterized by the relentless accumulation of mature CD5+ B cells' (B1 B cells, according to the new nomenclature') and by a remarkably high frequency of autoimmune phen~mena,~ For these reasons, B-CLL has been widely used as a model for the study of lymphoproliferative disorders and has given a great impulse to the study of the role of CD5' B cells in autoimmunity.From these studies CD5' B-CLL cells have emerged as a crossroad between malignant and autoreactive B cells.Enough information is now available to put the unique biological and clinical features of B-CLL into a unifying perspective.The essence of the problem to be reviewed is threefold.First, CD5+ B-CLL B cells express low to undetectable amounts of surface immunoglobulins SI^).^Second, B-CLL B cells accumulate in the GO phase of the cell Third, the pathogenic autoantibodies (Abs), detectable in up to 30% of the patients, are usually polyclonal and target-re-stri~ted.~.~,'They are directed against hematopoietic antigens expressed on the surface of red blood cells and, more rarely, of platelets and may lead to severe autoimmune hemolytic anemia and/or thromb~cytopenia.~"~'These features led us to ask which is the actual normal counterpart of B-CLL B lymphocyte and how the molecular events that result in the malignant phenotype relate to the development of autoimmune manifestations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., & Stevenson, F. K. (1999) · Blood · doi:10.1182/blood.v94.6.1848 · Cited by 2,783
Broad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
Kitada, S., Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krajewski, S., Wang, H.-G., Zhang, X., Bullrich, F., Croce, C. M., et al. (1998) · Blood · doi:10.1182/blood.v91.9.3379 · Cited by 651
Lymphoid Malignancies: the dark side of B-cell differentiation
Shaffer, A. L., Rosenwald, A., & Staudt, L. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri953 · Cited by 419
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia
Ahn, I. E., Underbayev, C., Albitar, A., Herman, S. E. M., Tian, X., Maric, I., Arthur, D. C., Wake, L., Pittaluga, S., Yuan, C. M., et al. (2017) · Blood · doi:10.1182/blood-2016-06-719294 · Cited by 341
Metadata
- Authors
- Caligaris-Cappio, F.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1996-04-01
- Volume
- 87
- Issue
- 7
- Pages
- 2615-2620
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2341863517
- Cited by
- 195
- References
- 0
- FWCI
- 12.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. https://app.cochat.ai/papers/10.1182/blood.v87.7.2615.bloodjournal8772615
- The paper
- Caligaris-Cappio, F. (1996). B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood. https://doi.org/10.1182/blood.v87.7.2615.bloodjournal8772615
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.